ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

38,564Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 5176

$2.03M Total Retail Price of All Prescriptions

Rank: 51 out of 5176

926 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 926 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 926 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 32,484 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 2,429 2,083 1 1
METOPROLOL TARTRATE 1,627 1,354 2 6
AMLODIPINE BESYLATE 1,356 1,150 3 2
FUROSEMIDE 1,164 1,000 4 8
LEVOTHYROXINE SODIUM 1,119 1,008 5 4
OMEPRAZOLE 1,072 904 6 3
RANITIDINE HCL 922 787 7 36
LISINOPRIL 669 529 8 5
METFORMIN HCL 655 498 9 7
WARFARIN SODIUM 574 538 10 13
CLOPIDOGREL 543 451 11 26
TAMSULOSIN HCL 513 464 12 20
ENALAPRIL MALEATE 491 418 13 22
DONEPEZIL HCL 485 485 14 28
HYDROCHLOROTHIAZIDE 424 366 15 10
PLAVIX 411 344 16 29
GABAPENTIN 401 286 17 21
LOSARTAN POTASSIUM 384 329 18 14
PREDNISONE 355 330 19 52
POTASSIUM CHLORIDE 353 278 20 34
ATORVASTATIN CALCIUM 348 277 21 9
OXYCODONE-ACETAMINOPHEN 341 236 S2 22 101
MIRTAZAPINE 320 302 23 45
CITALOPRAM HBR 314 286 24 31
GLIPIZIDE 302 259 25 63
CARVEDILOL 299 278 26 24
SERTRALINE HCL 295 239 27 30
ALBUTEROL SULFATE 292 290 28 99
IPRATROPIUM BROMIDE 290 287 29 135
AZITHROMYCIN 288 240 30 42
IBUPROFEN 283 219 31 72
NOVOLIN R 268 246 32 191
QUETIAPINE FUMARATE 267 221 33 75
NAPROXEN 266 222 34 95
ATENOLOL 253 236 35 12
NAMENDA 244 244 36 47
DIOVAN 243 215 37 19
DIGOXIN 241 196 38 56
FAMOTIDINE 239 215 39 58
HYDRALAZINE HCL 236 187 40 73
LACTULOSE 234 176 41 87
NYSTATIN 230 219 42 168
ALENDRONATE SODIUM 229 204 43 18
NEXIUM 210 174 44 16
FLUTICASONE PROPIONATE 208 179 45 38
RISPERIDONE 207 199 46 78
CLOTRIMAZOLE-BETAMETHASONE 206 157 47 94
FLUOCINONIDE 203 176 48 165
TRAMADOL HCL 200 124 49 40
LANTUS 199 182 50 66
CARBIDOPA-LEVODOPA 189 181 51 98
JANUVIA 186 131 52 25
ZOLPIDEM TARTRATE 186 155 52 17
NYSTATIN-TRIAMCINOLONE 176 173 54 142
SANTYL 173 95 55 124
CLOBETASOL PROPIONATE 172 155 56 130
FINASTERIDE 170 157 57 69
LEVETIRACETAM 170 126 57 92
TRAZODONE HCL 166 157 59 71
ADVAIR DISKUS 164 145 60 32
ALLOPURINOL 161 138 61 41
HYDROCORTISONE 157 116 62 265
MEGESTROL ACETATE 151 140 R 63 263
LYRICA 151 102 63 133
ISOSORBIDE DINITRATE 148 132 65 288
CYMBALTA 140 97 66 90
SPIRIVA 138 116 67 54
TRIAMCINOLONE ACETONIDE 136 112 68 125
LATANOPROST 136 136 68 185
FENOFIBRATE 134 91 70 102
NOVOLOG 134 113 70 168
PROAIR HFA 130 126 72 60
ISOSORBIDE MONONITRATE ER 129 100 73 44
SINGULAIR 127 113 74 62
NIFEDIPINE ER 127 83 74 48
GLIPIZIDE ER 126 106 76 117
SSD 126 109 76 216
CRESTOR 124 96 78 15
PHENYTOIN SODIUM EXTENDED 124 99 78 232
DIVALPROEX SODIUM 124 110 78 104
AMMONIUM LACTATE 120 77 81 91
PRANDIN 118 104 82 150
AVODART 118 104 82 107
GLYBURIDE-METFORMIN HCL 117 102 R 84 76
METOPROLOL SUCCINATE 117 113 84 11
BRIMONIDINE TARTRATE 113 113 86 244
OXYBUTYNIN CHLORIDE 110 104 87 227
CLONIDINE HCL 108 61 88 79
HALOPERIDOL 108 83 88 145
VESICARE 107 81 90 210
SEROQUEL 106 101 91 166
SYMBICORT 105 84 92 120
FOSINOPRIL SODIUM 105 78 92 105
PANTOPRAZOLE SODIUM 104 91 94 61
MUPIROCIN 102 74 95 182
INSULIN SYRINGE 101 92 96 137
CIPROFLOXACIN HCL 99 87 97 84
GLYBURIDE 98 72 R 98 67
TERAZOSIN HCL 96 96 99 158
DILTIAZEM 24HR CD 95 74 100 119
VALPROIC ACID 94 81 101 195
HEPARIN SODIUM 93 88 102 241
PATANOL 93 84 102 158
LOPERAMIDE 92 47 104 329
LIPITOR 90 77 105 51
LOVASTATIN 89 49 106 46
GLIMEPIRIDE 89 83 106 37
ESCITALOPRAM OXALATE 88 88 108 89
DIOVAN HCT 87 73 109 39
CALCITRIOL 87 87 109 261
LOSARTAN-HYDROCHLOROTHIAZIDE 85 69 111 35
NOVOLIN 70-30 85 85 111 287
CYCLOBENZAPRINE HCL 84 67 R 113 143
TRAVATAN Z 84 78 113 234
COLCRYS 81 80 115 170
GLIPIZIDE XL 81 40 115 83
LANTUS SOLOSTAR 80 22 117 70
VENTOLIN HFA 80 58 117 64
METOCLOPRAMIDE HCL 79 66 119 176
LEVEMIR FLEXPEN 78 72 120 200
BACLOFEN 77 40 121 173
CEPHALEXIN 76 60 122 189
PAROXETINE HCL 76 76 122 93
DETROL LA 75 70 124 249
KETOCONAZOLE 75 75 124 233
CEFUROXIME 75 62 124 273
BENZTROPINE MESYLATE 75 72 R 124 201
MECLIZINE HCL 72 63 128 81
MONTELUKAST SODIUM 71 60 129 123
AMITRIPTYLINE HCL 70 33 R 130 177
DOXAZOSIN MESYLATE 69 57 131 103
DORZOLAMIDE-TIMOLOL 68 68 132 374
LEVEMIR 68 59 132 252
EXELON 67 67 134 162
CLOTRIMAZOLE 67 46 134 296
OLANZAPINE 67 62 134 140
ACTOS 66 52 137 85
MELOXICAM 65 56 138 53
LEVOFLOXACIN 64 64 139 109
CALCIUM ACETATE 62 43 140 336
ENOXAPARIN SODIUM 62 61 140 305
DILTIAZEM HCL 61 59 142 316
ZALEPLON 60 60 143 472
DOXYCYCLINE HYCLATE 59 46 144 247
SPIRONOLACTONE 57 31 145 88
JANUMET 56 30 146 77
ECONAZOLE NITRATE 56 56 146 340
FLOVENT HFA 55 51 148 203
PREDNISOLONE ACETATE 54 53 149 538
NATEGLINIDE 53 40 150 272
PRAVASTATIN SODIUM 52 52 151 23
LUMIGAN 51 51 152 423
DICLOFENAC SODIUM 51 33 152 160
LAMOTRIGINE 51 37 152 289
NOVOLIN N 50 50 155 304
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.